{
    "Trade/Device Name(s)": [
        "EUROIMMUN Anti-Desmoglein 1 ELISA (IgG)",
        "EUROIMMUN Anti-Desmoglein 3 ELISA (IgG)",
        "Anti-Desmoglein 1 ELISA (IgG)",
        "Anti-Desmoglein 3 ELISA (IgG)"
    ],
    "Submitter Information": "EUROIMMUN US INC.",
    "510(k) Number": "K091969",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBO"
    ],
    "Summary Letter Date": "August 2, 2010",
    "Summary Letter Received Date": "August 9, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR\u00a7866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Desmoglein 1 IgG antibodies",
        "Desmoglein 3 IgG antibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "ELISA"
    ],
    "Methodologies": [
        "Qualitative determination",
        "Semi-quantitative determination"
    ],
    "Submission Type(s)": [
        "Test kit"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN Anti-Desmoglein 1/3 ELISA (IgG) for detection of IgG antibodies against desmoglein 1 and 3 associated with pemphigus foliaceus and pemphigus vulgaris",
    "Indications for Use Summary": "Intended for the qualitative or semi-quantitative determination of IgG class antibodies against desmoglein in serum and plasma to aid in diagnosis of pemphigus foliaceus (PF) and pemphigus vulgaris (PV), used in conjunction with other laboratory and clinical findings",
    "fda_folder": "Immunology"
}